Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 6/20 | 0.55 |
| ▸ | CA2 | P00918 | 6/20 | 0.55 |
| ▸ | CES2 | O00748 | 2/20 | 0.53 |
| ▸ | CES1 | P23141 | 2/20 | 0.53 |
| ▸ | PLK1 | P53350 | 1/20 | 0.52 |
| ▸ | PARP1 | P09874 | 1/20 | 0.50 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.50 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.50 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | CRHBP | P24387 | 1/20 | 0.46 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.46 |
| ▸ | F10 | P00742 | 1/20 | 0.46 |
| ▸ | GSK3B | P49841 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28861868 | 0.84 | ELANE (0.53) | MAPTNPC1RAB9ASMN1; SMN2PKM | |
| SCHEMBL19454923 | 0.83 | CA1 (0.53) | MAPTCA1CA2NPC1RAB9A | |
| SCHEMBL7915810 | 0.81 | PLK1 (0.71) | MAPTCA1CA2CES2CES1 | |
| SCHEMBL28468999 | 0.81 | ACACB (0.47) | MAPTCA1CA2TP53ALOX15 | |
| SCHEMBL28467015 | 0.81 | KMT2A (0.56) | MAPTPLK1PARP10NPC1RAB9A | |
| SCHEMBL19435693 | 0.80 | MAPT (0.45) | MAPTNPC1TP53RAB9ASMN1; SMN2 | |
| SCHEMBL28459416 | 0.80 | NPC1 (0.61) | CA1CA2CES2CES1PLK1 | |
| SCHEMBL31325039 | 0.80 | CES2 (0.59) | MAPTCES2CES1PARP1NPC1 | |
| SCHEMBL19724896 | 0.79 | CA1 (0.47) | MAPTCA1CA2NPC1RAB9A | |
| SCHEMBL7733506 | 0.79 | ALDH1A1 (0.48) | MAPTCES2CES1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111747904-A | Polyfluoroalkenyl substituted oxazole compound and preparation method thereof | 南京工业大学 | 2020-10-09 | — | — | CN | claimed |
| CN-119552129-A | Preparation method and application of fully substituted 5,5' -bisoxazole compound | 广东工业大学 | 2025-03-04 | — | — | CN | disclosed |
| CN-115043752-A | Beta, beta-dibromo enamide and preparation method thereof | 天津中医药大学 | 2022-09-13 | — | — | CN | disclosed |
| CN-113480533-B | Preparation method of 3, 4-pyridine diimides derivatives | 赣南师范大学 | 2022-08-02 | — | — | CN | disclosed |
| CN-113480533-A | Preparation method of 3, 4-pyridine diimides derivatives | 赣南师范大学 | 2021-10-08 | — | — | CN | disclosed |
| CN-111747904-A | Polyfluoroalkenyl substituted oxazole compound and preparation method thereof | 南京工业大学 | 2020-10-09 | — | — | CN | disclosed |
| CN-110156668-A | A method of synthesis 4- Polyfluoroalkyl -2,6- diaryl substituted pyridine compound | 福州大学 | 2019-08-23 | — | — | CN | disclosed |
| US-20170291885-A1 | METHOD FOR PREPARING ENAMIDE COMPOUND AND RUTHENIUM COMPLEX CATALYST USED THEREIN | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2017-10-12 | — | — | US | disclosed |
| US-20170291885-A1 | METHOD FOR PREPARING ENAMIDE COMPOUND AND RUTHENIUM COMPLEX CATALYST USED THEREIN | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2017-10-12 | — | — | US | disclosed |
| US-6399787-B1 | TRANSITION METAL COMPLEX | PENN STATE RESEARCH FOUNDATION | 2002-06-04 | — | — | US | disclosed |
| WO-1999059721-A1 | CATALYTIC ASYMMETRIC HYDROGENATION, HYDROFORMYLATION, AND HYDROVINYLATION VIA TRANSITION METAL CATALYSTS WITH PHOSPHINES AND PHOSPHITES | THE PENN STATE RESEARCH FOUNDATION (US) | 1999-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170291885-A1 | METHOD FOR PREPARING ENAMIDE COMPOUND AND RUTHENIUM COMPLEX CATALYST USED THEREIN | ENY2, ENO1, IDH1 | MAPT 4231/4885CA1 425/4885CA2 614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.